Ozempic Users Face Unexpected Social Backlash, New Study Reveals

Drugs like Ozempic and Wegovy are often celebrated as game-changers for weight loss. But a new study from Rice University reveals a hidden social cost: people who use these medications may actually face more judgment than those who never lose weight at all.

Glucagonlike peptide-1 (GLP-1) medications have become a hot topic nationwide. From celebrity endorsements to everyday conversations, these drugs are widely described as breakthroughs that help people shed significant pounds. However, the social experience of using them is far more complicated than many realize.

The research, led by Erin Standen, assistant professor of psychological sciences at Rice University, was published in the International Journal of Obesity. Her co-authors include Sean Phelan, professor of health services research at the Mayo Clinic, and Janet Tomiyama, professor of psychology at UCLA.

“We expected there might be some stigma around using a GLP-1,” Standen said. “But what surprised us was the extent of it.”

In the study, participants evaluated a fictional person based on their weight history. The person either lost weight using a GLP-1 medication, lost weight through diet and exercise, or did not lose weight at all.

A clear pattern emerged. Participants viewed those who used GLP-1 medications more negatively than those who lost weight through traditional methods. Even more striking, people rated the GLP-1 user worse than someone who had not lost any weight.

“The GLP-1 users were socially penalized not just compared to someone who lost weight through diet and exercise,” Standen said. “They were also rated more harshly than someone who didn’t lose weight in the first place.”

These results paint a more complex picture of weight stigma. Losing weight does not automatically remove social bias. Instead, it may simply change how that judgment is expressed.

“There’s this idea that if you lose weight, you might escape stigma,” Standen said. “But what we’re seeing is that people may face judgment at multiple points. They may be judged for their weight and for how they choose to manage it.”

This issue is especially important as GLP-1 medications become more widely used and discussed. Much of the judgment appears to be tied to perception rather than actual outcomes.

“There’s a narrative that using these medications is ‘taking the easy way out,'” Standen said. “And that belief seems to shape how people are judged.”

The researchers also looked at a common situation among people who stop using GLP-1 medications. Many discontinue treatment because of cost, insurance limits, or side effects. When they stop, weight regain is common.

The study found that this scenario also carries social consequences. Participants viewed individuals who regained weight more negatively than those who lost weight and kept it off, regardless of whether the weight loss came from medication or lifestyle changes.

“There’s a lot of stigma tied to weight regain in general,” Standen said. “And that doesn’t seem to depend much on how the weight was lost in the first place.”

According to Standen, these findings raise concerns that go beyond social attitudes. Weight stigma has been consistently linked to negative mental and physical health outcomes. These include stress, avoiding medical care, and unhealthy coping strategies.

“If people feel judged for the choices they’re making about their health, that can influence what they’re willing to do,” she said. “It can affect whether they seek care, whether they talk openly with providers, and how they manage their health overall.”

As GLP-1 medications continue to enter the mainstream, understanding these social effects becomes increasingly important.

“This is a moment where these treatments are really entering the mainstream,” Standen said. “So understanding the social side of that is critical.”

This research is part of a broader effort to encourage healthier choices without reinforcing stigma. Standen said her goal is to better understand how people can be supported without feeling judged.

“There’s such a strong cultural script around weight and what a ‘healthy’ body should look like,” she said. “And those messages can get in the way of people doing what’s actually best for them.”

She hopes the findings will help shift public attitudes.

“Ultimately, any form of stigma related to someone’s body or their health choices is not helpful,” Standen said. “People should be able to make decisions that are right for them without fear of being judged.”

Source: ScienceDaily